Marie-Josèphe Goudier

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial

Henri Roché, P. Fumoleau, M. Spielmann et al. · Journal of Clinical Oncology · 2006 · 572 citations · Full text

Medicine, Oncology, Pharmacology +16

Epirubicin Increases Long-Term Survival in Adjuvant Chemotherapy of Patients With Poor-Prognosis, Node-Positive, Early Breast Cancer: 10-Year Follow-Up Results of the French Adjuvant Study Group 05 Randomized Trial

Jacques Bonneterre, Henri Roché, Pierre Kerbrat et al. · Journal of Clinical Oncology · 2005 · 274 citations · Full text

Medicine, Oncology, Pharmacology +17

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

Érick Gamelin, E Danquechin‐Dorval, Y. Dumesnil et al. · Cancer · 1996 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

Érick Gamelin, M. Boisdron‐Celle, R. Delva et al. · Journal of Clinical Oncology · 1998 · 159 citations

Medicine, Oncology, Pharmacology +17

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results

P. Fumoleau, Henri Roché, Pierre Kerbrat et al. · Annals of Oncology · 2005 · 108 citations · Full text

Medicine, Cardiology, Oncology +17